Low Dose Vs Conventional Rituximab Regimen in Pemphigus Vulgaris – A Retrospective Single Centre Comparative Analysis to Assess the Clinical Efficacy and Cost-Effectiveness

Low Dose Vs Conventional Rituximab Regimen in Pemphigus Vulgaris – A Retrospective Single Centre Comparative Analysis to Assess the Clinical Efficacy and Cost-Effectiveness

Background: Rituximab (RTX) is considered the first-line treatment for pemphigus vulgaris (PV), a B-cell-mediated autoimmune bullous disease. However, no clear consensus on the optimum dosage has been achieved yet. Objectives: To compare the clinical efficiency and cost-effectiveness of a low-dose (...

Full description

Saved in:
Bibliographic Details
Main Authors: Amuthavalli Kanagarajan, Reena Rai, Shanmugasekar Chandrasekaran, Mahadevan Krishnaswamy, Bharathi Sivakumar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-07-01
Series:Indian Dermatology Online Journal
Subjects:
biologics
pemphigus vulgaris
rituximab
Online Access:https://journals.lww.com/10.4103/idoj.idoj_534_24
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items